BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

10 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Preparation and biological activities of potential vasopressin photoaffinity labels.EBI
University of Sherbrooke
 
Vasopressin trisulphide: synthesis, NMR study and affinity studies with V1 and V2 subtypes receptorsEBI
TBA
 
Potent, non-peptidic oxytocin receptor antagonists from a natural sourceEBI
TBA
New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.EBI
Université
Dicarbavasopressin antagonist analogues exhibit reduced in vivo agonist activity.EBI
Smith Kline & French Laboratories
Design, synthesis, and biological activity of a peptide mimic of vasopressin.EBI
Smith Kline and French Laboratories
Potent antagonists of vasopressin antidiuretic activity that lack the beta,beta-cyclopentamethylene-beta-mercaptopropionic acid substitution at position 1.EBI
TBA
Potent vasopressin antagonists lacking the proline residue at position 7.EBI
TBA
Novel vasopressin analogues that help define a minimum effective antagonist pharmacophore.EBI
TBA
Structure-activity relationships of novel vasopressin antagonists containing C-terminal diaminoalkanes and (aminoalkyl)guanidines.EBI
Smith Kline & French Laboratories